1. S111 Differences in characteristics and outcomes in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. (15th November 2016) Authors: Ramjug, S; Hussain, N; Hurdman, J; Billings, C; Elliot, CA; Kiely, DG; Sabroe, I; Rajaram, S; Swift, AJ; Condliffe, R Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P23 Predictors of mortality in progressive fibrosing interstitial lung disease patients treated with Nintedanib: real-world data from a single ILD specialist centre. (11th November 2022) Authors: Stranks, L; Newman, K; Garfoot, T; Morris, H; Zakis, K; Swale, J; Greaves, M; Stanel, S; Ramjug, S; Avram, C; Blaikley, J; Leonard, C; Hayton, C; Rivera-Ortega, P Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P168 Reduced Gas Transfer (tlco) Predicts Poor Outcome In Patients With Pulmonary Hypertension And Heart Failure With Preserved Ejection Fraction. (10th November 2014) Authors: Hussain, N; Ramjug, S; Billings, C; Hurdman, J; Elliot, CA; Condliffe, R; Kiely, DG Journal: Thorax Issue: Volume 69(2014)Supplement 2 Page Start: A148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P30 Real-world tolerability study of nintedanib in patients with progressive fibrosing interstitial lung disease compared to patients with idiopathic pulmonary fibrosis. (11th November 2022) Authors: Newman, K; Garfoot, T; Stranks, L; Morris, H; Zakis, K; Swale, J; Greaves, M; Stanel, S; Ramjug, S; Avram, C; Blaikley, J; Leonard, C; Hayton, C; Rivera-Ortega, P Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗